These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20933338)

  • 41. [Ophthalmic disorders as a manifestation of Parkinson's disease].
    Chesnokova NB; Pavlenko TA; Ugrumov MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):124-131. PubMed ID: 29053133
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glutathione depletion and overproduction both initiate degeneration of nigral dopaminergic neurons.
    Garrido M; Tereshchenko Y; Zhevtsova Z; Taschenberger G; Bähr M; Kügler S
    Acta Neuropathol; 2011 Apr; 121(4):475-85. PubMed ID: 21191602
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Common pathophysiology affecting diabetic retinopathy and Parkinson's disease.
    Tian T; Li Z; Lu H
    Med Hypotheses; 2015 Oct; 85(4):397-8. PubMed ID: 26141638
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Myeloperoxidase in the neurodegenerative process of Parkinson's disease].
    Teismann P
    Dtsch Med Wochenschr; 2014 Jan; 139(3):99-102. PubMed ID: 24277448
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuroinflammation in Parkinson's disease: a target for neuroprotection?
    Hirsch EC; Hunot S
    Lancet Neurol; 2009 Apr; 8(4):382-97. PubMed ID: 19296921
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of dopaminergic and cholinergic neurons in the monkey mesopontine tegmentum.
    Herrero MT; Hirsch EC; Javoy-Agid F; Obeso JA; Agid Y
    Brain Res; 1993 Oct; 624(1-2):281-5. PubMed ID: 7902770
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Anaesthesia and Parkinson's disease].
    Chhor V; Karachi C; Bonnet AM; Puybasset L; Lescot T
    Ann Fr Anesth Reanim; 2011; 30(7-8):559-68. PubMed ID: 21530145
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuronal vulnerability in Parkinson's disease.
    Hirsch EC; Faucheux B; Damier P; Mouatt-Prigent A; Agid Y
    J Neural Transm Suppl; 1997; 50():79-88. PubMed ID: 9120427
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adipose-derived human mesenchymal stem cells induce long-term neurogenic and anti-inflammatory effects and improve cognitive but not motor performance in a rat model of Parkinson's disease.
    Schwerk A; Altschüler J; Roch M; Gossen M; Winter C; Berg J; Kurtz A; Akyüz L; Steiner B
    Regen Med; 2015 May; 10(4):431-46. PubMed ID: 26022763
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A tale on animal models of Parkinson's disease.
    Bezard E; Przedborski S
    Mov Disord; 2011 May; 26(6):993-1002. PubMed ID: 21626544
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The retina in Parkinson's disease.
    Archibald NK; Clarke MP; Mosimann UP; Burn DJ
    Brain; 2009 May; 132(Pt 5):1128-45. PubMed ID: 19336464
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurotrophic factors for the treatment of Parkinson's disease.
    Sullivan AM; Toulouse A
    Cytokine Growth Factor Rev; 2011 Jun; 22(3):157-65. PubMed ID: 21689963
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Animal models of Parkinson's disease in rodents induced by toxins: an update.
    Hirsch EC; Höglinger G; Rousselet E; Breidert T; Parain K; Feger J; Ruberg M; Prigent A; Cohen-Salmon C; Launay JM
    J Neural Transm Suppl; 2003; (65):89-100. PubMed ID: 12946051
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Parkinson's disease and enhanced inflammatory response.
    Stojkovska I; Wagner BM; Morrison BE
    Exp Biol Med (Maywood); 2015 Nov; 240(11):1387-95. PubMed ID: 25769314
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Marker for a preclinical diagnosis of Parkinson's disease as a basis for neuroprotection.
    Berg D
    J Neural Transm Suppl; 2006; (71):123-32. PubMed ID: 17447423
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Parkinson's disease.
    Kalia LV; Lang AE
    Lancet; 2015 Aug; 386(9996):896-912. PubMed ID: 25904081
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dopaminergic neurons degenerate by apoptosis in Parkinson's disease.
    Hirsch EC; Hunot S; Faucheux B; Agid Y; Mizuno Y; Mochizuki H; Tatton WG; Tatton N; Olanow WC
    Mov Disord; 1999 Mar; 14(2):383-5. PubMed ID: 10091646
    [No Abstract]   [Full Text] [Related]  

  • 58. [Parkinson's disease: pathogenesis, aetiology, symptoms, diagnostics, and its course].
    de Baat C; van Stiphout MAE; Lobbezoo F; van Dijk KD; Berendse HW
    Ned Tijdschr Tandheelkd; 2018 Oct; 125(10):509-515. PubMed ID: 30317371
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Retinal Alterations Predict Early Prodromal Signs of Neurodegenerative Disease.
    Casciano F; Zauli E; Celeghini C; Caruso L; Gonelli A; Zauli G; Pignatelli A
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338966
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Does retina play a role in Parkinson's Disease?
    Mohana Devi S; Mahalaxmi I; Aswathy NP; Dhivya V; Balachandar V
    Acta Neurol Belg; 2020 Apr; 120(2):257-265. PubMed ID: 31965540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.